Amazon (AMZN) Stock Closes at All-Time High of $255.28,Anthropic Partnership and AWS Momentum Reshape Growth

Amazon (NASDAQ: AMZN) shares closed at $255.28 on April 22, marking an all-time high closing price for the stock and reflecting a market capitalisation sitting above $2.74 trillion as investors continued to absorb the implications of the company's expanded commitment to Anthropic and the ongoing acceleration of Amazon Web Services.

The Anthropic partnership, which Amazon formalised with a commitment of up to $25 billion on top of its prior $8 billion investment, has been interpreted by analysts as confirmation that AWS is winning a disproportionate share of the AI infrastructure spending cycle, with Anthropic simultaneously pledging to spend more than $100 billion on AWS technologies over the coming decade.

Amazon's custom Trainium chip business has doubled its annualised revenue run rate to over $20 billion, a figure that gives the company growing independence from NVIDIA silicon in AI training workloads and represents a strategic asset whose value is only beginning to be fully recognised in the stock's valuation.

Truist Securities and several other research firms have cited the Anthropic arrangement as a signal that Trainium is being adopted not as a hedge but as a genuine primary compute platform for frontier AI training, which would position AWS to extract significantly more margin from AI workloads than a pure commodity cloud infrastructure provider would achieve.

Amazon also disclosed this week that CEO Andrew Jassy sold approximately 31,000 shares on April 17 in a transaction valued at around $7.9 million, a routine insider sale that attracted attention given the stock's record levels but is widely understood as part of a pre-arranged trading plan rather than a directional signal.

A separate but notable headline involved Amazon entering the weight-loss drug market with a new GLP-1 programme, a move that sent shares of rivals including Hims and Hers Health lower as the market priced in the competitive threat of Amazon's distribution scale entering the pharmacy and telehealth adjacency.

Amazon also announced its acquisition of Globalstar for $11.6 billion, a deal that extends the company's satellite connectivity ambitions and adds a component to its logistics and remote commerce infrastructure that could become increasingly relevant as the company expands beyond its traditional geographic footprints.

Q1 2026 earnings are scheduled for April 29, and the market is positioning for a report that will need to show continued Azure-competitive growth from AWS alongside evidence that margin expansion can be sustained even as capital expenditure on AI data centres runs at historically elevated levels.

The stock's 52-week range of $169.35 to $258.60 illustrates how dramatically the recovery from the Iran war's initial market shock has compressed into a short window, with AMZN now sitting at the upper extreme of that band and carrying significant earnings execution expectations heading into the report.

Trading volume on April 22 came in at approximately 43 million shares, below the 50.82 million daily average, suggesting the record close was achieved on relatively subdued participation, which analysts often interpret as a more durable move than those driven by elevated speculative volume.